FR7155M - - Google Patents

Info

Publication number
FR7155M
FR7155M FR138141A FR138141A FR7155M FR 7155 M FR7155 M FR 7155M FR 138141 A FR138141 A FR 138141A FR 138141 A FR138141 A FR 138141A FR 7155 M FR7155 M FR 7155M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR138141A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR100617A priority Critical patent/FR1525186A/fr
Application filed filed Critical
Priority to FR138141A priority patent/FR7155M/fr
Priority to IL29661A priority patent/IL29661A/xx
Priority to CH435868A priority patent/CH491958A/fr
Priority to DE1770062A priority patent/DE1770062C3/de
Priority to US715981A priority patent/US3494917A/en
Priority to NL686804392A priority patent/NL144944B/xx
Priority to GB8261/70A priority patent/GB1209669A/en
Priority to GB05424/68A priority patent/GB1209668A/en
Priority to DK136968AA priority patent/DK118021B/da
Application granted granted Critical
Publication of FR7155M publication Critical patent/FR7155M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR138141A 1967-03-29 1968-01-31 Expired FR7155M (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR100617A FR1525186A (fr) 1967-03-29 1967-03-29 Nouvelles pénicillines et procédé de préparation
FR138141A FR7155M (fr) 1967-03-29 1968-01-31
IL29661A IL29661A (en) 1967-03-29 1968-03-19 Tetrahydroisoquinolyl penicillins and process of preparation
CH435868A CH491958A (fr) 1967-03-29 1968-03-25 Procédé de préparation de nouveaux dérivés de l'acide 6-amino pénicillanique
DE1770062A DE1770062C3 (de) 1967-03-29 1968-03-26 Tetrahydroisochinolylpenicilline, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen
US715981A US3494917A (en) 1967-03-29 1968-03-26 Synthetic penicillins and process for their preparation
NL686804392A NL144944B (nl) 1967-03-29 1968-03-28 Werkwijze voor de bereiding van 6-aminopenicillaanzuurderivaten.
GB8261/70A GB1209669A (en) 1967-03-29 1968-03-29 New isoquinaldic acid derivatives, and processes for preparing them
GB05424/68A GB1209668A (en) 1967-03-29 1968-03-29 New penicillins and processes for preparing them
DK136968AA DK118021B (da) 1967-03-29 1968-03-29 Fremgangsmåde til fremstilling af 6-aminopenicillansyrederivater.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR100617A FR1525186A (fr) 1967-03-29 1967-03-29 Nouvelles pénicillines et procédé de préparation
FR138141A FR7155M (fr) 1967-03-29 1968-01-31

Publications (1)

Publication Number Publication Date
FR7155M true FR7155M (fr) 1969-08-04

Family

ID=26175147

Family Applications (2)

Application Number Title Priority Date Filing Date
FR100617A Expired FR1525186A (fr) 1967-03-29 1967-03-29 Nouvelles pénicillines et procédé de préparation
FR138141A Expired FR7155M (fr) 1967-03-29 1968-01-31

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR100617A Expired FR1525186A (fr) 1967-03-29 1967-03-29 Nouvelles pénicillines et procédé de préparation

Country Status (8)

Country Link
US (1) US3494917A (fr)
CH (1) CH491958A (fr)
DE (1) DE1770062C3 (fr)
DK (1) DK118021B (fr)
FR (2) FR1525186A (fr)
GB (2) GB1209668A (fr)
IL (1) IL29661A (fr)
NL (1) NL144944B (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394276B2 (en) 2011-10-14 2016-07-19 Bristol-Myers Squibb Company Substituted 1,2,3,4-tetrahydro-2,6-naphthyridines as factor XIa inhibitors
US9447110B2 (en) 2011-10-14 2016-09-20 Bristol-Myers Squibb Company Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors
US9453018B2 (en) 2014-10-01 2016-09-27 Bristol-Myers Squibb Company Pyrimidinones as factor XIa inhibitors
US9738655B2 (en) 2013-03-25 2017-08-22 Bristol-Myers Squibb Company Tetrahydroisoquinolines containing substituted azoles as factor XIa inhibitors
US9777001B2 (en) 2014-01-31 2017-10-03 Bristol-Myers Squibb Company Macrocycles with aromatic P2′ groups as factor xia inhibitors
US10081623B2 (en) 2014-09-04 2018-09-25 Bristol-Myers Squibb Company Diamide macrocycles that are FXIa inhibitors
US10273236B2 (en) 2014-01-31 2019-04-30 Bristol-Myers Squibb Macrocyclic factor XIa inhibitors bearing heterocyclic groups

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531615D0 (en) * 1985-12-23 1986-02-05 Zambeletti Spa L Compounds
HU212427B (en) * 1991-12-19 1996-06-28 Gyogyszerkutato Intezet Process for producing dl-, d- and l-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acids and their derivatives containing urethane-type n-protecting groups
US9079929B2 (en) 2011-10-14 2015-07-14 Bristol-Myers Squibb Company Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors
TR201807316T4 (tr) 2012-10-12 2018-06-21 Squibb Bristol Myers Co Bir faktör XIa inhibitörünün kristalli formları.
US9403774B2 (en) 2012-10-12 2016-08-02 Bristol-Myers Squibb Company Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors
WO2014059202A1 (fr) 2012-10-12 2014-04-17 Bristol-Myers Squibb Company Composés de tétrahydroisoquinoléine substitués par guanidine comme inhibiteurs du facteur xia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3174964A (en) * 1959-12-10 1965-03-23 Pfizer & Co C Derivatives of 6-aminopenicillanic acid
US3043831A (en) * 1960-07-18 1962-07-10 Doyle Frank Peter Synthetic penicillins

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9944625B2 (en) 2011-10-14 2018-04-17 Bristol-Myers Squibb Company Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors
US9394276B2 (en) 2011-10-14 2016-07-19 Bristol-Myers Squibb Company Substituted 1,2,3,4-tetrahydro-2,6-naphthyridines as factor XIa inhibitors
US10906886B2 (en) 2011-10-14 2021-02-02 Bristol-Myers Squibb Company Substituted 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazines as factor xia inhibitors
US9725435B2 (en) 2011-10-14 2017-08-08 Bristol-Myers Squibb Company Substituted 4,5,6,7-tetrahydropyrazolo[4,3-c]pyridines as factor XIa inhibitors
US10000466B2 (en) 2011-10-14 2018-06-19 Bristol-Myers Squibb Company Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitors
US10208021B2 (en) 2011-10-14 2019-02-19 Bristol-Myers Squibb Company Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors
US9447110B2 (en) 2011-10-14 2016-09-20 Bristol-Myers Squibb Company Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors
US9738655B2 (en) 2013-03-25 2017-08-22 Bristol-Myers Squibb Company Tetrahydroisoquinolines containing substituted azoles as factor XIa inhibitors
US10273236B2 (en) 2014-01-31 2019-04-30 Bristol-Myers Squibb Macrocyclic factor XIa inhibitors bearing heterocyclic groups
US9777001B2 (en) 2014-01-31 2017-10-03 Bristol-Myers Squibb Company Macrocycles with aromatic P2′ groups as factor xia inhibitors
US10081623B2 (en) 2014-09-04 2018-09-25 Bristol-Myers Squibb Company Diamide macrocycles that are FXIa inhibitors
US10336754B2 (en) 2014-10-01 2019-07-02 Bristol-Myers Squibb Company Pyrimidinones as factor XIa inhibitors
US9453018B2 (en) 2014-10-01 2016-09-27 Bristol-Myers Squibb Company Pyrimidinones as factor XIa inhibitors
US11053247B2 (en) 2014-10-01 2021-07-06 Bristol-Myers Squibb Company Pyrimidinones as factor XIA inhibitors

Also Published As

Publication number Publication date
US3494917A (en) 1970-02-10
IL29661A (en) 1972-01-27
NL6804392A (fr) 1968-09-30
DE1770062C3 (de) 1979-08-02
DE1770062A1 (de) 1971-09-16
DK118021B (da) 1970-06-29
FR1525186A (fr) 1968-05-17
GB1209669A (en) 1970-10-21
GB1209668A (en) 1970-10-21
DE1770062B2 (de) 1978-11-30
CH491958A (fr) 1970-06-15
NL144944B (nl) 1975-02-17

Similar Documents

Publication Publication Date Title
AU5765369A (fr)
AT298283B (fr)
AU2528767A (fr)
AU1273466A (fr)
AU610966A (fr)
AU3054676A (fr)
AU25066A (fr)
AU1614766A (fr)
AU1677166A (fr)
AU1763766A (fr)
AU1868267A (fr)
NL6804392A (fr)
BE711562A (fr)
BE711561A (fr)
BE711497A (fr)
BE711378A (fr)
BE710379A (fr)
BE709738A (fr)
BE709462A (fr)
BE709456A (fr)
BE709269A (fr)
BE709247A (fr)
BE708909A (fr)
BE708327A (fr)
BE706892A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse